The Future of Diabetes Care: Exploring Inhaled Insulin
Designed for healthcare professionals, this learning journey focuses on inhaled insulin and its transformative impact on postprandial glucose control.
With expertly curated micro-learning sessions and journal clubs, this program, supported by Mannkind Corporation, offers a dynamic platform to enhance your clinical practice and stay at the forefront of cutting-edge diabetes therapies.
Why This Program?
- Engage with Experts: Gain insights from leading researchers and practitioners in diabetes management.
- Learn with Flexibility: Benefit from accessible, concise microlearning modules designed for busy professionals.
- Expand Your Expertise: Participate in journal clubs to critically evaluate research and understand its application in clinical settings.
- Drive Better Outcomes: Learn practical strategies to incorporate inhaled insulin into your practice effectively.
Program Highlights
Journal Club Series
The first Journal Club of this series, “A Multi-Center Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults with Type 1 Diabetes,” featured renowned presenters Dr. Klara Klein (MD, PhD), Dr. Roy Beck (MD, PhD), and Dr. Irl Hirsch (MD), with a Q&A moderated by Casey Wells, PharmD.
Missed the live event? You can now access the CME/CPD accredited e-learning course based on this Journal Club. Revisit the groundbreaking research and discussions at your convenience while earning credits.
New Infographic: Comparing Inhaled Insulin with Usual Care for T1D
Explore key insights from the latest study by Irl B. Hirsch et al., comparing Inhaled Insulin plus Basal Insulin vs. Usual Care in adults with Type 1 Diabetes. Our newly launched infographic breaks down the findings in a clear and engaging way, helping you quickly grasp the study’s impact on diabetes management.
📊 What You’ll Learn:
✔ Efficacy and safety comparisons between inhaled insulin and usual care.
✔ Potential benefits for glycemic control and patient experience.
✔ Key takeaways from the Diabetes Care 2024 publication.
🔗 Check it out now! Access the infographic here.
Join the 7th Edition of the ATTD Journal Club!
Don’t miss the opportunity to dive into the latest advancements in diabetes care at the ATTD Journal Club! This edition will focus on the INHALE-3 Extension Study, exploring the use of Inhaled Technosphere Insulin plus Insulin Degludec for adults with Type 1 Diabetes.
Event Highlights:
📌 Expert Presenters: Dr. Grazia Aleppo, Dr. Beck (MD, PhD), and Dr. Hirsch (MD)
📌 Article Discussion: Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes: the INHALE-3 Extension Study
📌 Live Q&A: Moderated by Dr. Mahira Saiyed
Why Attend?
✔ Gain expert insights from leading researchers.
✔ Participate in an engaging discussion and live Q&A.
✔ Stay ahead with cutting-edge diabetes research.
Register Here
📢 Bonus: Can’t make it live? The session will be available on-demand in the ATTD Educational Portal, along with a CME/CPD-accredited activity.
Empowering You Through Knowledge
This program isn’t just about learning—it’s about driving change. By participating, you’ll gain:
- Improved confidence in prescribing and managing inhaled insulin therapy.
- Tools to educate and support patients in achieving better adherence and outcomes.
- A deeper understanding of emerging trends and the future of diabetes care.
Collaborate with a Global Network
Through this program, connect with a vibrant community of healthcare professionals, researchers, and thought leaders dedicated to advancing diabetes management. Stay informed, inspired, and equipped to provide the best possible care to your patients.
Ready to transform your practice?
Join us in shaping the future of diabetes care—one session at a time.